Biomarker testing has been proven to be a beneficial treatment option for cancer patients. In 2022, we were able to listen to a couple of patients share their biomarker testing experience during our lung cancer programs and they’ve attributed their overall survival to this invaluable treatment option.
HB 85 could be heard as early as Monday, February 6, 2023! We’ll continue to keep you posted.
WJMS Radio Owner, Lung cancer survivor, advocate, and participant in the 2022 lung cancer programs, Jayme Knox, shares her experience with biomarker testing and why it’s important to make this treatment option readily available to all patients.
***Update February 6, 2023: Georga Biomarker Bill, HB 85, passed out of the House Committee and will move onto the Rules Committee soon.